Palmitoylethanolamide (PEA) vs PQQ (Pyrroloquinoline Quinone)

Mechanism

Endocannabinoid-like lipid that activates PPAR-alpha and indirectly enhances endocannabinoid tone. Potent anti-inflammatory and analgesic without acting directly on CB1/CB2. Reduces mast cell activation, neuroinflammation, and chronic pain.

Contraindications

• None established at standard doses

Mechanism

PQQ activates PGC-1alpha via CREB phosphorylation, directly stimulating mitochondrial biogenesis — the formation of new mitochondria. It acts as a redox cycling agent capable of thousands of catalytic oxidation-reduction cycles (compared to ~4 for vitamin C), providing exceptional antioxidant capacity. PQQ also modulates NMDA receptor signaling and promotes nerve growth factor (NGF) synthesis, supporting neuronal health and cognitive function.

Standard Dosing

10-20mg daily

Timing

With breakfast. Can combine in same meal with CoQ10.

Cycle Duration

ongoing

Side Effects

• Rare: headache
• Mild GI discomfort at higher doses
• Insomnia if taken late

Contraindications

• Pregnancy/lactation (insufficient safety data)

Best Stacking Partners